
Ministers to delay UK junk food advertising ban until next year
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
UK ministers are set to delay the implementation of rules that would ban unhealthy food advertising before 9pm in order to change guidance to allow brand marketing following heavy lobbying from the industry.
The government has promised that children will no longer be exposed to adverts for junk food products before 9pm on TV — or at any time online — in an effort to tackle childhood obesity.
But the rules were also set to potentially cover branded advertising — using company names, for example, even if unhealthy products were not shown — under guidance issued by the Committees of Advertising Practice (CAP) and the Advertising Standards Authority (ASA), which write and enforce the advertising codes, respectively.
On Thursday ministers are to announce that pure brand advertising should be excluded from the scope of the restrictions, according to three people with knowledge of the plans.
They are expected to delay implementation of the rules to make changes so the ASA can act instead on the precise intention of the rules, the people said.
The announcement will mean that food brands can continue to promote corporate social responsibility commitments or advertise healthier products once the rules come into force.
The restrictions were due to take effect from October 1 but are now expected to be delayed until the new year. They cover adverts promoting products with high fat, salt or sugar, known as less healthy food (LHF). Read More UK Officials Call for TikTok Ban After New EU Restrictions
One government official confirmed the legislation would be pushed back until January 5 after the ASA 'interpreted' the rules 'differently' to how ministers had intended and how they 'were originally portrayed'.
The person added that all the main retailers had signed a letter agreeing to voluntarily implement the 9pm ban from October.
Another government official confirmed there would be a 'four-month pause' while the legislation was amended. The ASA declined to comment.
A Department of Health spokesperson said: 'Obesity robs children of the best start in life and sets them up for a lifetime of health problems, which costs the NHS billions.
'We have secured a unique and public commitment from advertisers and broadcasters so that from October 1 2025, adverts for identifiable less healthy products will not be shown on TV before 9pm or at any time online, and this will be a legal duty from January 2026.'
In an update to a consultation on the rules in January, the CAP said the revised guidance was likely to clarify that for advertisers 'even if your ad does not explicitly refer to or feature an LHF product — it may still be restricted under law, where persons in the UK could reasonably be expected to be able to identify your ad as being for an LHF product or LHF products'.
But consumer brands and retailers have opposed any extension of the rules to cover brands as well as products, with broadcasters warning of a material hit to their revenues at a time when the advertising market is weak.
Marks and Spencer chair Archie Norman told the Financial Times in April that the plan to ban junk food advertising meant the retailer may not be able to justify the expense of a Christmas food advert, describing it as 'regulating to stop people talking about mince pies'.
But a joint statement from the Advertising Association, Channel 4, ISBA, ITV, Paramount, and STV last month said the government had been clear that the law 'does not intend to (and does not in fact) prevent any food or drink brands from advertising'.
The move is likely to outrage health campaigners who are concerned about allowing advertising for brands that are clearly associated with unhealthy food.
The original legislation was proposed by Conservative government but delayed by former prime minister Rishi Sunak until 2025.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
an hour ago
- Newsweek
Woman Buys $3 Bag of Pens at Thrift Store—Then Discovers Their True Value
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. An Ohio woman has revealed how a seemingly ordinary bag of pens purchased from a local thrift store ended up being worth substantially more. In a video posted to TikTok under the handle @cosmicdealheather, the eagle-eyed thrifter revealed how a bag of pens she recently purchased for just $3 ended up being worth somewhere in the region of $100. "You might be wondering why you would buy a bag of pens that's pretty much worthless?" she says on the clip. "The answer is not if they are drug rep pens." "I have been selling things on eBay for 19 years and have sold different pharmaceutical rep pieces over that time period," user @cosmicdealheather, who requested her real name be omitted from this story, told Newsweek. "Certain ones have a market just because it's funny to say you own a Viagra pen or want an Adderall note pad to match your prescription," the poster said. To understand how this all started, you have to go back to 2006 and the publication of a report in the American Medical Association Journal of Ethics. It concluded that even the cheapest of gifts, whether they be T-shirts, cuddly toys or, of course, pens, were capable of influencing physician prescribing decisions. By 2008, the pharmaceutical industry reached an industrywide agreement that brought an end to gift giving of this kind and, in the process, turned those gifts still in circulation into something approaching collectors' items. At the time of writing, there are currently over 2,100 listings under the search term "Drug Rep Pen" on eBay. Highlights include a metal Zoloft pen on offer for $89 and a pair of brand-new OxyContin pens for sale at $79.99. Cosmicdealheather said that pens linked to companies making "painkillers, antidepressants, stimulants, sleep aids, or benzos [benzodiazepines] tend to be the ones people want." She added that, while there is a market for these pens on sites like eBay, it can pay off to cast your net a little wider when it comes to making money off them. "You can find them at thrift stores, estate sales, garage sales, anywhere someone might have old stuff they want to get rid of," the poster said. This new bag of pens contains a few interesting ones and will fetch a decent price once she divides it up into a few different listings. However, there are even more valuable items out there. "I haven't found any of the really expensive ones," the poster said. However, she has had luck with other pharma merch in the recent past. "I find drug rep merch a few times a year while thrifting," she said. "Last year, I got a whole box full of Zoloft tissues for free at a garage sale, so maybe one big score a year." Though it is far from an exact science, Cosmicdealheather said that the demand for these items means anyone scouring the shelves at their local thrift store would be wise to take a closer look at any pens up for sale. "If they see a bag of pens or something at the thrift store and it's full of pharmaceutical pens, it might have value," the poster said.


New York Post
3 hours ago
- New York Post
I popped a pimple in the ‘triangle of death' and ended up in urgent care on 4 prescription drugs
Please don't squeeze. That's the warning from mom of three Lish Marie, who ended up in urgent care — and filling four different prescriptions — after simply popping a pimple on her face. But the spot in question sat in what dermatologists call the 'triangle of death' — and her blemish blunder could have actually killed her. 5 Lish Marie is warning people against popping a pimple in the 'triangle of death' after it landed her in urgent care. TikTok/lishmarie1 5 Her face got swollen and her smile was crooked within hours of popping the pimple just below her nose. TikTok/lishmarie1 Lish (@lishmarie1) tried to pop a cyst pimple just below her nostril, a pretty common place for zits to grow. Within four hours, things got 'bad,' she said, with that side of her face swelling so much that when she tried to smile, only the opposite side actually raised into a grin. She said the results were 'extremely painful' and doctors at urgent care put her on four medications to take care of the infection, including steroids and antibiotics. Lish's pimple fell inside the 'triangle of death,' an area of the face where a popped pimple can release bacteria into the brain, leading to potentially life-threatening infections. 'Popping pimples in the center of the face can be particularly dangerous,' NYC-based dermatologist Dr. Mark Strom said in a TikTok last year. 'The area of the face from the bridge of the nose down to the corners of the mouth has veins that connect directly to the brain via a blood vessel called the cavernous sinus,' he said. 5 Fortunately, after four medications, she was back to normal within a few days. TikTok/lishmarie1 When you squeeze a zit there, you leave a small open wound through which bacteria (like from your hands or the air) can enter the bloodstream. This can lead to infection, which may then be carried to the brain. Complications can include blindness, stroke, paralysis and even death. Another TikTokker named Hope (@imlesbianflavored) revealed in 2023 that in her case, it lead to a staph infection that was 'worse than childbirth' and left her with a scar. Well aware of the 'triangle of death,' Lish knew she got lucky: 'I think I caught mine extremely quick, within hours so I'm on a ton of meds,' she said. Twenty-four hours later she was doing better, though she noted that her smile was still a bit 'crooked,' and three days later she was '100% back to normal.' While lots of commenters chimed in to say that they'd popped plenty of pimples in the area without incident, others shared similarly scary experiences. 'Happened to my daughter. We spent a week in the hospital and she had to have surgery on her face,' wrote one mom, while another said her son was hospitalized when his turned into a staph infection. 'I almost died from this. It's no joke, was hospitalized for a week and a half and had surgery,' wrote yet another commenter. 5 'Popping pimples in the center of the face can be particularly dangerous,' NYC-based dermatologist Dr. Mark Strom said in a TikTok last year. TikTok/dermarkologist 5 The triangle is 'the area of the face from the bridge of the nose down to the corners of the mouth,' Dr. Strom explained. Khunatorn – If you absolutely must pop a pimple — after trying a spot treatment or pimple patches — dermatologist Dr. Mamina Turegano says to begin by sterilizing your hands and the area with rubbing alcohol. 'Then poke the pimple with a diabetic lancet, which has a very tiny needle, to open the surface with a small prick that 'won't cause too much damage,' she said in an Instagram video. Apply slight pressure with two cotton swabs to let the contents drain out. 'When popping a pimple it's very important that you're not applying a lot of pressure otherwise you're gonna get a lot more inflammation and result in scarring,' Turegano advised. But she, too, advises against touching anything in the 'triangle of death.' 'Really, don't mess with it. Spot treatment it or see a derm,' Tuergano insisted.


Business Wire
3 hours ago
- Business Wire
BostonGene Publishes Landmark Study Providing Clinical and Analytical Validation for Its Multimodal RNA and DNA Assay
WALTHAM, Mass.--(BUSINESS WIRE)-- BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced the publication of a pivotal study, ' Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort, ' in Communications Medicine, a high-impact journal in the Nature portfolio. The study underscores the BostonGene Tumor Portrait™ assay as a clinically robust, regulatory-grade platform that forms the foundation of BostonGene's AI-powered platform, purpose-built for precision oncology and designed to accelerate therapeutic development and enhance clinical data collection. 'Delivering clinically validated multimodal data from a single tumor sample—and interpreting it through an immune-focused, AI-enabled lens—represents a transformative advancement for oncology drug development.' The Tumor Portrait™ assay integrates DNA and RNA sequencing into a single end-to-end test, delivering a multimodal view of each tumor. Approved under CLIA, CAP and the New York State Department of Health, the platform enhances patient stratification, predictive biomarker discovery and clinical trial enrollment—all critical to reducing the risks associated with drug development and improving clinical trial success rates. The study details the implementation of highly stable clinical RNA-seq protocol, deployed in ready-to-use clinical settings and tested across more than 2,200 tumors, demonstrating high reproducibility, strong clinical actionability (98% of cases) and advanced detection of alterations, fusions, immune signatures, tumor microenvironment profiles and AI-based predictive classifications. 'Delivering clinically validated multimodal data from a single tumor sample—and interpreting it through an immune-focused, AI-enabled lens—represents a transformative advancement for oncology drug development,' said Alexander Bagaev, PhD, Chief Product Officer at BostonGene. 'By combining DNA and RNA sequencing in one assay, our platform enables deeper biological understanding of the tumor microenvironment and genetics, smarter patient selection and more confident, data-driven decisions throughout the drug development lifecycle. This validation sets a new benchmark for translational research and diagnostic innovation.' About BostonGene Corporation BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients. For more information, visit